- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF (MSOX)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: MSOX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -10.82% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta - | 52 Weeks Range 2.14 - 68.40 | Updated Date 06/29/2025 |
52 Weeks Range 2.14 - 68.40 | Updated Date 06/29/2025 |
Upturn AI SWOT
AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF
ETF Overview
Overview
The AdvisorShares MSOS 2x Daily ETF (MSOX) seeks daily investment results, before fees and expenses, of 200% of the performance of the AdvisorShares Pure US Cannabis ETF (MSOS). It is a leveraged ETF focused on the U.S. cannabis sector, aiming to amplify the daily returns of MSOS.
Reputation and Reliability
AdvisorShares specializes in actively managed ETFs, some with a thematic focus. Their reputation is built on offering innovative investment solutions, but the leveraged nature of this ETF adds complexity.
Management Expertise
AdvisorShares has a team experienced in managing thematic and actively managed ETFs, including those focused on the cannabis industry. Managing leveraged products requires specific expertise in risk management and trading.
Investment Objective
Goal
To achieve daily investment results, before fees and expenses, corresponding to two times (200%) the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS).
Investment Approach and Strategy
Strategy: Leveraged ETF aiming for 2x daily exposure to the performance of MSOS, which tracks U.S. cannabis companies.
Composition Primarily invests in financial instruments such as swap agreements, futures contracts, and other derivatives to achieve its leveraged exposure to MSOS. Does not directly hold cannabis company stocks.
Market Position
Market Share: MSOX has a relatively small market share compared to non-leveraged cannabis ETFs due to its higher risk profile.
Total Net Assets (AUM): 19390000
Competitors
Key Competitors
- AdvisorShares Pure US Cannabis ETF (MSOS)
- Roundhill Cannabis ETF (WEED)
- Amplify ETF Trust - Amplify Alternative Harvest ETF (MJ)
Competitive Landscape
The competitive landscape includes both leveraged and unleveraged cannabis ETFs. MSOX offers amplified daily returns, attracting risk-seeking investors, but its leveraged structure can lead to significant losses. Competitors like MSOS provide direct exposure to the U.S. cannabis market without leverage, appealing to investors with a lower risk tolerance. Advantages of MSOX is its potential for higher returns, while disadvantages are higher volatility and risk of principal loss due to compounding.
Financial Performance
Historical Performance: Historical performance is highly volatile due to the leveraged nature. Long-term performance can deviate significantly from 2x the returns of MSOS due to compounding effects.
Benchmark Comparison: The ETF aims to achieve 2x the daily performance of MSOS, so its benchmark is essentially 2x MSOS's daily returns. Performance can vary substantially due to the impact of compounding and fees.
Expense Ratio: 1.75
Liquidity
Average Trading Volume
The average trading volume of MSOX is moderate, which can affect the ease of buying and selling shares.
Bid-Ask Spread
The bid-ask spread can be wider than non-leveraged ETFs, reflecting the higher trading costs and risk associated with the fund.
Market Dynamics
Market Environment Factors
MSOX is heavily influenced by the regulatory environment surrounding cannabis in the U.S., investor sentiment towards the cannabis industry, and the performance of MSOS. Economic factors also play a role, impacting overall market sentiment and investment flows.
Growth Trajectory
The growth trajectory of MSOX is dependent on the performance and growth of U.S. cannabis companies and investor appetite for leveraged exposure to the sector. Changes to strategy and holdings are influenced by the fund's objective to maintain 2x leverage to MSOS.
Moat and Competitive Advantages
Competitive Edge
MSOX offers a unique value proposition for investors seeking leveraged exposure to the U.S. cannabis market. Its competitive edge lies in its 2x leverage, allowing investors to potentially amplify their gains (and losses) compared to non-leveraged ETFs. However, the leveraged nature also increases risk and potential for significant losses due to compounding. Its focused approach to the US cannabis market may appeal to investors who believe in that market's potential.
Risk Analysis
Volatility
MSOX exhibits high volatility due to its leveraged nature. Daily fluctuations can be significant, making it unsuitable for risk-averse investors.
Market Risk
The ETF is subject to market risk associated with the cannabis industry, including regulatory changes, competition, and shifts in consumer preferences. Leveraged ETFs also face the risk of compounding, where losses can be magnified and difficult to recover from.
Investor Profile
Ideal Investor Profile
The ideal investor is a sophisticated investor with a high-risk tolerance, a strong understanding of leveraged ETFs, and a short-term investment horizon. They should be seeking to capitalize on short-term movements in the U.S. cannabis sector.
Market Risk
MSOX is best suited for active traders seeking short-term gains and willing to accept substantial risk. It is not appropriate for long-term investors or those with a low-risk tolerance.
Summary
The AdvisorShares MSOS 2x Daily ETF (MSOX) provides leveraged exposure to the U.S. cannabis market, targeting 2x the daily performance of MSOS. While it offers the potential for amplified returns, it also carries significant risks due to its leveraged structure and compounding effects. It's suitable for short-term, high-risk traders familiar with leveraged ETFs. Investors should carefully consider their risk tolerance and investment horizon before investing in MSOX.
Similar ETFs
Sources and Disclaimers
Data Sources:
- AdvisorShares website
- ETF.com
- Yahoo Finance
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investing in ETFs involves risk, including the potential loss of principal. Leveraged ETFs are not suitable for all investors.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The US Cannabis ETF primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

